Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
350
-
Total 13F shares, excl. options
-
43,586,046
-
Shares change
-
-3,200,931
-
Total reported value, excl. options
-
$3,771,528,836
-
Value change
-
-$268,277,033
-
Put/Call ratio
-
196%
-
Number of buys
-
191
-
Number of sells
-
-121
-
Price
-
$86.57
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2017
452 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q3 2017.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 350 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,586,046 shares
.
Largest 10 shareholders include MORGAN STANLEY (5,783,106 shares), GOLDMAN SACHS GROUP INC (5,547,708 shares), CITIGROUP INC (4,905,780 shares), BNP PARIBAS ARBITRAGE, SA (4,013,360 shares), BANK OF AMERICA CORP /DE/ (2,604,157 shares), JPMORGAN CHASE & CO (2,028,544 shares), UBS Group AG (1,584,688 shares), WELLS FARGO & COMPANY/MN (1,449,462 shares), CREDIT SUISSE AG/ (1,258,613 shares), and ASSETMARK, INC (1,239,051 shares).
This table shows the top 350 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.